Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism

[1]  F. Q. Ribeiro.  The meta-analysis , 2017, Brazilian journal of otorhinolaryngology.

[2]  H. Shimokawa,et al.  Long-term dietary nitrite and nitrate deficiency causes the metabolic syndrome, endothelial dysfunction and cardiovascular death in mice , 2017, Diabetologia.

[3]  G. Gerber,et al.  Antibiotic effects on gut microbiota and metabolism are host dependent. , 2016, The Journal of clinical investigation.

[4]  H. Tilg,et al.  Gut microbiome and liver diseases , 2016, Gut.

[5]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[6]  G. King,et al.  Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture , 2016, Diabetes.

[7]  F. Fåk,et al.  Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. , 2015, Molecular nutrition & food research.

[8]  Tamotsu Kato,et al.  Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver , 2015, PloS one.

[9]  Jing Li,et al.  Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease , 2015, Scientific Reports.

[10]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[11]  Yuko Sakurai,et al.  Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes , 2014, Diabetes Care.

[12]  K. Cusi,et al.  Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis , 2014, Hepatology.

[13]  D. Motooka,et al.  Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota , 2014, Scientific Reports.

[14]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[15]  Masoumeh Sikaroodi,et al.  Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[17]  S. Rabot,et al.  Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.

[18]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[19]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[20]  D. Torres,et al.  Features, diagnosis, and treatment of nonalcoholic fatty liver disease. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  John C. Wooley,et al.  Ultrafast clustering algorithms for metagenomic sequence analysis , 2012, Briefings Bioinform..

[22]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[23]  K. Rioux,et al.  The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[24]  I. Tohnai,et al.  Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease , 2012, BMC Gastroenterology.

[25]  C. Kahn,et al.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.

[26]  Panos N. Papapanou,et al.  Diabetes mellitus and periodontitis: a tale of two common interrelated diseases , 2011, Nature Reviews Endocrinology.

[27]  E. Quigley,et al.  The role of the gut microbiota in nonalcoholic fatty liver disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[28]  Rob Knight,et al.  Human oral, gut, and plaque microbiota in patients with atherosclerosis , 2010, Proceedings of the National Academy of Sciences.

[29]  C. Kahn,et al.  Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. , 2010, Cell metabolism.

[30]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[31]  Rob Knight,et al.  High-fat diet determines the composition of the murine gut microbiome independently of obesity. , 2009, Gastroenterology.

[32]  N. Lang,et al.  Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks. , 2008, Journal of clinical periodontology.

[33]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[34]  Thorkild Karring,et al.  Clinical Periodontology and Implant Dentistry , 2008 .

[35]  M. Membrez,et al.  Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Sarabjeet Singh,et al.  The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. , 2007, American heart journal.

[37]  D. Fine,et al.  Aggregatibacter actinomycetemcomitans and Its Relationship to Initiation of Localized Aggressive Periodontitis: Longitudinal Cohort Study of Initially Healthy Adolescents , 2007, Journal of Clinical Microbiology.

[38]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[39]  K. Hermansen,et al.  Fatty acid‐induced effect on glucagon secretion is mediated via fatty acid oxidation , 2007, Diabetes/metabolism research and reviews.

[40]  A. Kantarcı,et al.  Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. , 2007, Periodontology 2000.

[41]  Leming Shi,et al.  Using RNA sample titrations to assess microarray platform performance and normalization techniques , 2006, Nature Biotechnology.

[42]  Y. Kawashima,et al.  Antibody response after single-visit full-mouth ultrasonic debridement versus quadrant-wise therapy. , 2006, Journal of clinical periodontology.

[43]  Yoichiro Kitajima,et al.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease , 2006, Journal of Gastroenterology.

[44]  K. Kowdley,et al.  Natural History of Nonalcoholic Steatohepatitis , 2006, Journal of clinical gastroenterology.

[45]  Y. Kawashima,et al.  Elevated serum IgG titer and avidity to Actinobacillus actinomycetemcomitans serotype c in Japanese periodontitis patients. , 2005, Oral microbiology and immunology.

[46]  Bei B. Zhang,et al.  Glucagon and regulation of glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[47]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[48]  Robert J. Palmer,et al.  Communication among Oral Bacteria , 2002, Microbiology and Molecular Biology Reviews.

[49]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[50]  P. Arner.  Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.

[51]  R. Janeiro,et al.  "Red complex" (Bacteroides forsythus, Porphyromonas gingivalis, and Treponema denticola) in endodontic infections: a molecular approach. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[52]  S. Yamashita,et al.  Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.

[53]  S. Haffner,et al.  A Prospective Analysis of the HOMA Model: The Mexico City Diabetes Study , 1996, Diabetes Care.

[54]  S. Socransky,et al.  A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis. , 1981, Journal of periodontology.

[55]  L Axel,et al.  Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. , 1980, Radiology.

[56]  W. Mcarthur,et al.  Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism , 1979, Infection and immunity.

[57]  C. Roques,et al.  Fusobacterium nucleatum in periodontal health and disease. , 2011, Current issues in molecular biology.

[58]  Y. Khader,et al.  Periodontal status of diabetics compared with nondiabetics: a meta-analysis. , 2006, Journal of diabetes and its complications.

[59]  Sang Joon Kim,et al.  A Mathematical Theory of Communication , 2006 .

[60]  M. Burnet,et al.  The molecular approach , 2005 .

[61]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[62]  M. Listgarten.  Structure of the microbial flora associated with periodontal health and disease in man. A light and electron microscopic study. , 1976, Journal of periodontology.

[63]  W. Ketterl.  [Periodontal diseases]. , 1971, Der Zahnarzt; Colloquium med. dent.